Cargando…

Adaptive Boosting Based Personalized Glucose Monitoring System (PGMS) for Non-Invasive Blood Glucose Prediction with Improved Accuracy

In this paper, we present an architecture of a personalized glucose monitoring system (PGMS). PGMS consists of both invasive and non-invasive sensors on a single device. Initially, blood glucose is measured invasively and non-invasively, to train the machine learning models. Then, paired data and co...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Pradeep Kumar, Shin, Dong Ryeol, Memon, Mudasar Latif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278000/
https://www.ncbi.nlm.nih.gov/pubmed/32392841
http://dx.doi.org/10.3390/diagnostics10050285
_version_ 1783543249830412288
author Anand, Pradeep Kumar
Shin, Dong Ryeol
Memon, Mudasar Latif
author_facet Anand, Pradeep Kumar
Shin, Dong Ryeol
Memon, Mudasar Latif
author_sort Anand, Pradeep Kumar
collection PubMed
description In this paper, we present an architecture of a personalized glucose monitoring system (PGMS). PGMS consists of both invasive and non-invasive sensors on a single device. Initially, blood glucose is measured invasively and non-invasively, to train the machine learning models. Then, paired data and corresponding errors are divided scientifically into six different clusters based on blood glucose ranges as per the patient’s diabetic conditions. Each cluster is trained to build the unique error prediction model using an adaptive boosting (AdaBoost) algorithm. Later, these error prediction models undergo personalized calibration based on the patient’s characteristics. Once, the errors in predicted non-invasive values are within the acceptable error range, the device gets personalized for a patient to measure the blood glucose non-invasively. We verify PGMS on two different datasets. Performance analysis shows that the mean absolute relative difference (MARD) is reduced exceptionally to 7.3% and 7.1% for predicted values as compared to 25.4% and 18.4% for measured non-invasive glucose values. The Clarke error grid analysis (CEGA) plot for non-invasive predicted values shows 97% data in Zone A and 3% data in Zone B for dataset 1. Moreover, for dataset 2 results echoed with 98% and 2% in Zones A and B, respectively.
format Online
Article
Text
id pubmed-7278000
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72780002020-06-12 Adaptive Boosting Based Personalized Glucose Monitoring System (PGMS) for Non-Invasive Blood Glucose Prediction with Improved Accuracy Anand, Pradeep Kumar Shin, Dong Ryeol Memon, Mudasar Latif Diagnostics (Basel) Article In this paper, we present an architecture of a personalized glucose monitoring system (PGMS). PGMS consists of both invasive and non-invasive sensors on a single device. Initially, blood glucose is measured invasively and non-invasively, to train the machine learning models. Then, paired data and corresponding errors are divided scientifically into six different clusters based on blood glucose ranges as per the patient’s diabetic conditions. Each cluster is trained to build the unique error prediction model using an adaptive boosting (AdaBoost) algorithm. Later, these error prediction models undergo personalized calibration based on the patient’s characteristics. Once, the errors in predicted non-invasive values are within the acceptable error range, the device gets personalized for a patient to measure the blood glucose non-invasively. We verify PGMS on two different datasets. Performance analysis shows that the mean absolute relative difference (MARD) is reduced exceptionally to 7.3% and 7.1% for predicted values as compared to 25.4% and 18.4% for measured non-invasive glucose values. The Clarke error grid analysis (CEGA) plot for non-invasive predicted values shows 97% data in Zone A and 3% data in Zone B for dataset 1. Moreover, for dataset 2 results echoed with 98% and 2% in Zones A and B, respectively. MDPI 2020-05-07 /pmc/articles/PMC7278000/ /pubmed/32392841 http://dx.doi.org/10.3390/diagnostics10050285 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Anand, Pradeep Kumar
Shin, Dong Ryeol
Memon, Mudasar Latif
Adaptive Boosting Based Personalized Glucose Monitoring System (PGMS) for Non-Invasive Blood Glucose Prediction with Improved Accuracy
title Adaptive Boosting Based Personalized Glucose Monitoring System (PGMS) for Non-Invasive Blood Glucose Prediction with Improved Accuracy
title_full Adaptive Boosting Based Personalized Glucose Monitoring System (PGMS) for Non-Invasive Blood Glucose Prediction with Improved Accuracy
title_fullStr Adaptive Boosting Based Personalized Glucose Monitoring System (PGMS) for Non-Invasive Blood Glucose Prediction with Improved Accuracy
title_full_unstemmed Adaptive Boosting Based Personalized Glucose Monitoring System (PGMS) for Non-Invasive Blood Glucose Prediction with Improved Accuracy
title_short Adaptive Boosting Based Personalized Glucose Monitoring System (PGMS) for Non-Invasive Blood Glucose Prediction with Improved Accuracy
title_sort adaptive boosting based personalized glucose monitoring system (pgms) for non-invasive blood glucose prediction with improved accuracy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278000/
https://www.ncbi.nlm.nih.gov/pubmed/32392841
http://dx.doi.org/10.3390/diagnostics10050285
work_keys_str_mv AT anandpradeepkumar adaptiveboostingbasedpersonalizedglucosemonitoringsystempgmsfornoninvasivebloodglucosepredictionwithimprovedaccuracy
AT shindongryeol adaptiveboostingbasedpersonalizedglucosemonitoringsystempgmsfornoninvasivebloodglucosepredictionwithimprovedaccuracy
AT memonmudasarlatif adaptiveboostingbasedpersonalizedglucosemonitoringsystempgmsfornoninvasivebloodglucosepredictionwithimprovedaccuracy